|
1.Kang, G.H., et al., CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res, 2001. 61(7): p. 2847-51. 2.Ueki, T., et al., Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived. Oncogene, 2002. 21(13): p. 2114-7. 3.Jones, P.A. and S.B. Baylin, The fundamental role of epigenetic events in cancer. Nat Rev Genet, 2002. 3(6): p. 415-28. 4.Roberts, P.J. and C.J. Der, Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene, 2007. 26(22): p. 3291-310. 5.Davis, C.D. and E.O. Uthus, DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med (Maywood), 2004. 229(10): p. 988-95. 6.Baylin, S.B., S.A. Belinsky, and J.G. Herman, Aberrant methylation of gene promoters in cancer---concepts, misconcepts, and promise. J Natl Cancer Inst, 2000. 92(18): p. 1460-1. 7.Baylin, S.B., et al., Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res, 1998. 72: p. 141-96. 8.Baylin, S.B., et al., Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet, 2001. 10(7): p. 687-92. 9.Douer, D. and H.P. Koeffler, Retinoic acid enhances growth of human early erythroid progenitor cells in vitro. J Clin Invest, 1982. 69(4): p. 1039-41. 10.Krupitza, G., et al., Genes related to growth and invasiveness are repressed by sodium butyrate in ovarian carcinoma cells. Br J Cancer, 1996. 73(4): p. 433-8. 11.Douer, D. and H.P. Koeffler, Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells. J Clin Invest, 1982. 69(2): p. 277-83. 12.Lotan, R., D. Lotan, and P.G. Sacks, Inhibition of tumor cell growth by retinoids. Methods Enzymol, 1990. 190: p. 100-10. 13.Nagy, L., et al., Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell, 1997. 89(3): p. 373-80. 14.Glass, C.K. and M.G. Rosenfeld, The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev, 2000. 14(2): p. 121-41. 15.Dilworth, F.J. and P. Chambon, Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene, 2001. 20(24): p. 3047-54. 16.Bastien, J. and C. Rochette-Egly, Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene, 2004. 328: p. 1-16. 17.Duvic, M., et al., Molecular mechanisms of tazarotene action in psoriasis. J Am Acad Dermatol, 1997. 37(2 Pt 3): p. S18-24. 18.Nagpal, S., et al., Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin. J Invest Dermatol, 1996. 106(2): p. 269-74. 19.Kwong, J., et al., Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma. Int J Cancer, 2005. 113(3): p. 386-92. 20.Pallares, I., et al., Structure of human carboxypeptidase A4 with its endogenous protein inhibitor, latexin. Proc Natl Acad Sci U S A, 2005. 102(11): p. 3978-83. 21.Aagaard, A., et al., An inflammatory role for the mammalian carboxypeptidase inhibitor latexin: relationship to cystatins and the tumor suppressor TIG1. Structure, 2005. 13(2): p. 309-17. 22.Jing, C., et al., Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity. J Natl Cancer Inst, 2002. 94(7): p. 482-90. 23.Youssef, E.M., et al., Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers. Cancer Res, 2004. 64(7): p. 2411-7. 24.Mizuiri, H., et al., DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage. Cancer Sci, 2005. 96(9): p. 571-7. 25.Takai, N., et al., Discovery of epigenetically masked tumor suppressor genes in endometrial cancer. Mol Cancer Res, 2005. 3(5): p. 261-9. 26.Wu, C.C., et al., RARRES1 expression is significantly related to tumour differentiation and staging in colorectal adenocarcinoma. Eur J Cancer, 2006. 42(4): p. 557-65. 27.Schoen, R.E., The case for population-based screening for colorectal cancer. Nat Rev Cancer, 2002. 2(1): p. 65-70.
|